Stay updated on Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The type of intervention has been updated from version v2.13.3 to v2.14.0.
    Difference
    1.0%
    Check dated 2025-01-12T22:17:24.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Results were posted on December 17, 2024, following the previous submission of results on November 21, 2024.
    Difference
    1.0%
    Check dated 2024-12-22T07:17:16.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.3%
    Check dated 2024-12-14T23:12:06.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.
    Difference
    0.3%
    Check dated 2024-12-07T18:38:25.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    Results have been submitted, replacing the previous status of no results posted.
    Difference
    0.5%
    Check dated 2024-11-30T16:13:47.000Z thumbnail image
  8. Check
    53 days ago
    Change Detected
    Summary
    On November 21, 2024, new content was added, while on October 29, 2024, a detailed section regarding data download options and study information fields was removed.
    Difference
    14%
    Check dated 2024-11-23T05:15:59.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial page.